Jidong Dung Ezekiel, Ike Tarela Juliet, Taru Maigari Yusufu, Pwajok Juliet Y, Nwoga Charles Nnaemeka, Jidong John Ezekiel, Mwankon Shadrack B, Francis Christopher, Husain Nusrat
Division of Psychology and Mental Health, The University of Manchester, Manchester, UK.
Department of Sociology and Criminology, Teesside University, Middlesbrough, UK.
Clin Psychol Psychother. 2025 May-Jun;32(3):e70098. doi: 10.1002/cpp.70098.
Globally, suicide is the second leading cause of death for adolescents/young people aged 15-30-years old. The mainstream care for these affected persons is mostly unsuccessful due to limited culturally appropriate care.
This is a mixed-methods randomised controlled feasibility trial design. A culturally adapted manual-assisted psychological intervention (CaMaPI) was utilised to treat adolescents/young people with histories of self-harm and suicidal ideation. CaMaPI is a manualised intervention consisting of 10 sessions, grounded in psychoeducation and cognitive behavioural therapy. Participants aged 18-29 were screened for self-harm and suicidal ideation. N = 20 participants were randomised into CaMaPI (n = 10) or Treatment as Usual (TaU) (n = 10) groups. One focus group with n = 8 participants, and n = 3 individual interviews were conducted with the experimental group.
Satisfaction with intervention (CaMaPI, 100%; TaU, 50%). Reduction in self-harm and suicidal ideation was higher in CaMaPI on the suicide and self-harm scale at Md = 1.00 with z = -2.264, compared to TaU, Md = 3.00 with z = -0.378. Both groups showed no significant reduction in hopelessness. Emerging themes from the qualitative findings showed acceptance of self-harm and suicidal ideation as a treatable condition, mood management and behaviour modification, alongside cultural appropriateness and positive experience of the CaMaPI.
CaMaPI is feasible, culturally appropriate and acceptable in reducing self-harm and suicidal ideation in adolescents/young people with histories of self-harm and suicidal ideation in Nigeria. A fully powered randomised control trial is recommended to evaluate the clinical and cost-effectiveness of CaMaPI compared with TAU.
ClinicalTrials.gov (No. NCT06440031) KEY PRACTITIONER MESSAGE: Suicide is one of the leading causes of death among 15- to 29-year-olds globally. Seventy-three percent of all suicides and self-harm happen in low- and middle-income countries, including Nigeria. CaMaPI is acceptable, culturally appropriate and feasible for treating suicidal ideation and self-harm behaviours in adolescents and young people. CaMaPI is manualised and delivered with minimal resources by trained clinical psychology researchers.
在全球范围内，自杀是15至30岁青少年/年轻人的第二大死因。由于文化上适宜的护理有限，对这些受影响者的主流护理大多不成功。
这是一项混合方法随机对照可行性试验设计。采用一种文化适应的手册辅助心理干预（CaMaPI）来治疗有自我伤害和自杀意念史的青少年/年轻人。CaMaPI是一种手册化干预，包括10个疗程，基于心理教育和认知行为疗法。对18至29岁的参与者进行自我伤害和自杀意念筛查。N = 20名参与者被随机分为CaMaPI组（n = 10）或常规治疗（TaU）组（n = 10）。对实验组进行了一个有8名参与者的焦点小组和3次个人访谈。
对干预的满意度（CaMaPI组为100%；TaU组为50%）。在自杀和自我伤害量表上，CaMaPI组在自我伤害和自杀意念的降低方面高于TaU组，CaMaPI组的中位数（Md）为1.00，z值为 -2.264，而TaU组的Md为3.00，z值为 -0.378。两组在绝望感方面均无显著降低。定性研究结果中出现的新主题表明，将自我伤害和自杀意念视为可治疗的状况、情绪管理和行为改变得到了认可，同时体现了CaMaPI的文化适宜性和积极体验。
在尼日利亚，CaMaPI对于减少有自我伤害和自杀意念史的青少年/年轻人的自我伤害和自杀意念是可行的、文化上适宜的且可接受的。建议进行一项充分有力的随机对照试验，以评估CaMaPI与常规治疗相比的临床效果和成本效益。
ClinicalTrials.gov（编号：NCT06440031）关键从业者信息：自杀是全球15至29岁人群的主要死因之一。所有自杀和自我伤害事件的73%发生在低收入和中等收入国家，包括尼日利亚。CaMaPI对于治疗青少年和年轻人的自杀意念和自我伤害行为是可接受的、文化上适宜的且可行的。CaMaPI是手册化的，由训练有素的临床心理学研究人员以最少的资源进行实施。
